This is a past event. Registration is closed. View other Asia Pacific Medical Technology Association (APACMed) events.
The United Nations and World Health Organization have declared the COVID-19 situation as a global pandemic, bringing the business community into a tumultuous period of uncertainty.
As the wider and longer-term impact of COVID-19 becomes more apparent, organisations and corporations will be faced with significant challenges and business leaders will have an increasing number of concerns to consider as they prepare an effective response to mitigate the effects of COVID-19 on our way of life and the economy.
APACMed will like to invite you to participate in a high-level discussion with the senior leaders of several of our member companies and hear how organisations in Asia are tackling the longer-term impact of COVID-19.
The fireside chat will be moderated by McKinsey & Company, with participation from Baxter Healthcare, Siemens Healthineers, Terumo Asia Holdings and the Medical Technology Association of Australia.
This is the first in a series of webcast events planned by APACMed to support organisations gain a better overview of COVID-19's implications on business continuity.
Please note that this webinar is exclusive to APACMed members only. Login details will be shared via email to those who have registered for the event, closer to the event date.
Thank you.
Speakers
Ian Burgess
Chief Executive Officer at Medical Technology Association of Australia
https://www.mtaa.org.au/Ian is CEO of the Medical Technology Association of Australia, the national association representing companies in the medical device industry.
Ian is a director of the Asia Pacific Medical Technology Association, which is headquartered in Singapore, and is also a director and Vice Chair of Red Nose, formerly known as SIDS & Kids, a well-respected not-for-profit organisation that is dedicated to saving the lives of babies and children.
Ian has a varied career in both not-for-profit and commercial organisations and his previous CEO roles have included the Australian Dental Association (NSW), the Australian Orthopaedic Association and a private equity backed health business with more than 350 staff.
Ian is a member of the Australian Institute of Company Directors and holds an MBA from Macquarie University and a Bachelor of Economics from the Australian National University.
Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.
Probir has been with Terumo Corporation since 2012, and is currently responsible for
overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long term strategy of Terumo in Asia Pacific.
Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI).
Probir also has over a decade’s teaching experience, specifically around strategy, leadership
development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.
Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.
Andrew Frye is senior vice president and president, APAC of Baxter Healthcare. He joined Baxter in 2017 from DKSH Holdings Ltd., where he served as Global Head of Healthcare from 2015 to 2017. In that role, he oversaw a portfolio of pharmaceuticals, over-the-counter and device products across 13 countries. Previously, he served as vice president of Business Development from 2011 to 2014 for DKSH Healthcare. Earlier in his career, he held a number of commercial roles with increasing responsibility at Abbott Laboratories’ Pharmaceutical and Nutrition divisions.
Andrew received a bachelor’s degree in psychobiology from the University of Southern California and master’s degree in marketing from the Anderson School of Management at the University of California.
Elisabeth
Staudinger
President, Asia Pacific at Siemens Healthineers
https://www.siemens-healthineers.com/en-sg/Directly after graduating from college, Elisabeth Staudinger began her career with Siemens in 1998 at Global Procurement and Logistics in Munich. From 1999 until 2002, she was in charge of Siemens Procurement and Logistics Services in Shanghai. After holding several management positions at Siemens Healthcare in Germany and China, Elisabeth moved to Forchheim, Germany, in January 2009, where she assumed the role of Chief Executive Officer of the Refurbished Systems Business Unit. In November 2013, Elisabeth assumed the position of Healthcare Region Lead for ASEAN-Pacific in Singapore. Addition to her previous role as Region Lead for ASEAN-Pacific, Elisabeth has taken over the position of the president of Siemens Healthineers Greater China since January 2018. Since April 1, 2018, Elisabeth has taken over the position of President of Siemens Healthineers Asia Pacific. She is now based in Shanghai.
Elisabeth studied sinology and economics in Vienna, Nanjing, and Beijing and holds a master’s degree in both subjects. She is married and has one son.
Sponsors and Partners
Organizer
Asia Pacific Medical Technology Association (APACMed)
Founded in 2014, the Asia Pacific Medical Technology Association (APACMed) is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.
APACMed works proactively with bilateral, regional and lcoal government bodies to shape policies, demonstrate the value of innovation and promote regulatory convergence.